Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO
NCT03036995
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Vitiligo
Interventions
DRUG:
Apremilast
OTHER:
Placebo
Sponsor
Centre Hospitalier Universitaire de Nice